Please note that this is the scientific program planned for 2020. We are currently talking to all the speakers and players with a view to implementing the program in the same or very similar form for 2021. Updates will follow shortly.
Scientific program
Preliminary program – Tuesday, November 10, 2020
10:00-11:00 am
Registration
11:00-11:15 am
Welcome Address
11:15 am - 12:45 pm
Session I – Precision Medicine Addressing Tolerance and Inflammation
Keynote: Kordasti, Shahram (Kings College London, London, UK)
12:45–1:30 pm
LunchPoster Session I
1:30-3:00 pm
Session II – Cell-based Therapy in Hematology
Keynote: Ciceri, Fabio (IRCCS Ospedale San Raffaele, Milan, Italy)
3:00-3:30 pm
Break
3:30-4:30 pm
Session III – Industry
Industry Session sponsored by Novartis
4:30-4:45 pm
Break
4:45-6:00 pm
Session IV – Cell-based Therapy in Oncology
Keynote: Abken, Hinrich (University Hospital Regensburg, Regensburg, Germany)
6:00-6:15 pm
Break
6:15-7:00 pm
Evening Lecture
T cell engaging therapies: Blinatumomab and beyond
Keynote: Bargou, Ralf (Julius-Maximilians-Universität (JMU), Würzburg, Germany)
The evening lecture is supported by:
from 7:00 pm
Get-together
Preliminary program – Wednesday, November 11, 2020
9:00-10:15 am
Session V – Combining Cell Therapy and Immune Checkpoint Inhibitors
Keynote: Chabannon, Christian (Institut Paoli-Calmettes, Marseille, France)
10:15-10:30 am
Break
10:30-11:45 am
Session VI – Biomarkers and Immuno Monitoring
Keynote: Dienstmann, Rodrigo (Vall d'Hebron Institute of Oncology, Barcelona, Spain)
11:45 am -12:00 pm
Break
12:00 - 1:00 pm
Session VII - Industry
Industry Session sponsored by Gilead
1:00-1:45 pm
LunchPoster Session II
1:45-3:00 pm
Session VIII – Improving the Efficacy and Safety Profile of Cell Therapies
Keynote: t.b.a.
3:00-3:15 pm
Break
3:15-4:30 pm
Session IX – Cancer Vaccines and Vector-based Therapy
Keynote: Cathomen, Tony (Medical Center – University of Freiburg, Freiburg, Germany)
from 4:30 pm
End
